Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus

被引:6
|
作者
Arzamastseva, N. E. [1 ]
Lankin, V. Z. [1 ]
Konovalova, G. G. [1 ]
Tikhaze, A. K. [1 ]
Ageev, F. T. [1 ]
Lapina, V. [1 ]
Narusov, O. Yu. [1 ]
Mareev, V. Yu. [1 ]
Belenkov, Yu. N. [1 ]
机构
[1] Russia Minist Hlth, Inst Clin Cardiol, Russian Cardiol Res & Prod Ctr, Moscow, Russia
关键词
chronic heart failure; diabetes mellitus; lipid hydroperoxides; malonicdialdehyde; antioxidant enzymes;
D O I
10.1007/s10517-007-0052-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Parameters of oxidative stress were studied in patients with chronic heart failure and/or type 2 diabetes mellitus. Chronic heart failure was accompanied by severe oxidative stress, while in patients with type 2 diabetes mellitus the signs of oxidative stress were less pronounced. The intensity of free radical oxidation in patients with chronic heart failure and type 2 diabetes mellitus was not higher compared to patients with chronic heart failure.
引用
收藏
页码:207 / 209
页数:3
相关论文
共 50 条
  • [1] Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus
    N. E. Arzamastseva
    V. Z. Lankin
    G. G. Konovalova
    A. K. Tikhaze
    F. T. Ageev
    Yu. V. Lapina
    O. Yu. Narusov
    V. Yu. Mareev
    Yu. N. Belenkov
    [J]. Bulletin of Experimental Biology and Medicine, 2007, 143 : 207 - 209
  • [2] TELMISARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2
    Pavliukovych, N.
    Pavliukovych, O.
    Tryphonyuk, L.
    Kozar, M.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E153 - E153
  • [3] The incidence of chronic heart failure in patients with type 2 diabetes mellitus
    Yeshniyazov, N. B.
    Medovchshikov, V. V.
    Tereshchenko, E. A.
    Khasanova, E. R.
    Kobalava, Z. D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 253 - 253
  • [4] TELMISARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2
    Pavliukovych, N.
    Pavliukovych, O.
    Kozar, M.
    [J]. ATHEROSCLEROSIS, 2022, 355 : E330 - E330
  • [5] Effects of perindopril, telmisartan, and their combinations on clinical, functional, and oxidative stress parameters in patients with chronic heart failure and Type 2 diabetes mellitus
    Belenkov, Yu. N.
    Privalova, E. V.
    Zheleznykh, E. A.
    Danilogorskaya, Yu. A.
    Chekneva, I. S.
    Azizova, O. A.
    Aseychev, A. V.
    Shvachko, A. G.
    [J]. RUSSIAN JOURNAL OF CARDIOLOGY, 2010, (02): : 52 - 58
  • [6] CARDIORENAL SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
    Reznik, Elena
    Lazarev, Vladimir
    Komissarova, Maria
    Presnova, Evgeniya
    Nikitin, Igor
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [7] Heart failure in patients with type 2 diabetes mellitus
    Vlad, Adrian
    Serban, Viorel
    Timar, Romulus
    Darabantiu, Dan
    [J]. DIABETES, 2007, 56 : A588 - A588
  • [8] PREDICTORS OF KIDNEY EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC HEART FAILURE PATIENTS
    Berezin, Alexander
    Fushtey, Ivan
    Berezina, Tetiana
    Berezin, Oleksandr
    [J]. JOURNAL OF HYPERTENSION, 2024, 42
  • [9] Glycemic control on development of chronic heart failure in patients with type 2 diabetes mellitus
    Strongin, L. G.
    Pochinka, I. G.
    Konysheva, M. S.
    Morozova, E. P.
    [J]. DIABETES MELLITUS, 2012, 15 (02): : 17 - 21
  • [10] Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure
    Granberry, Mark C.
    Hawkins, Jason B.
    Franks, Amy M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (09) : 931 - 936